Sophar

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Sophar - overview

Established

2007

Location

Kigali, -, Rwanda

Primary Industry

Pharmaceuticals

About

Sophar Ltd is a technology-focused company that provides innovative software development and IT consulting services aimed at enhancing operational efficiency for various industries including finance, healthcare, and retail. Founded in 2007 in Kigali, Rwanda, Sophar Ltd specializes in software development and IT consulting. The company has participated in 2 deals, with the most recent investment occurring on January 22, 2013, when Fanisi Capital provided a loan of USD 1 mn. The total amount raised by the company stands at USD 2 mn.


Sophar Ltd specializes in delivering innovative solutions within the technology sector, focusing primarily on software development and IT consulting services. Their core offerings include customized software applications designed to enhance operational efficiency for businesses across various industries, including finance, healthcare, and retail. These solutions aim to streamline processes, improve data management, and facilitate better decision-making for their clients. Sophar Ltd has positioned its products to cater specifically to medium to large enterprises, with a client base that spans several geographical markets, including North America, Europe, and parts of Asia.


The company prioritizes addressing specific end use cases, such as automating repetitive tasks and integrating disparate systems, thereby providing significant value to its customers. Sophar Ltd generates revenue through a structured B2B model, primarily involving software licensing and consulting fees. The company engages with clients through long-term contracts that often include annual subscriptions for ongoing support and updates for their flagship software products. Typical transactions involve an initial setup fee followed by periodic payments for maintenance and upgrades, ensuring a continuous relationship with their clients.


Additionally, Sophar Ltd offers tiered pricing plans tailored to the specific needs of their clients, which may include varying levels of service and customization options. This structured approach not only fosters client loyalty but also enhances the company's revenue stability by securing recurring income streams. Sophar Ltd is focusing on developing new software products aimed at improving operational efficiencies for clients, with several products in the design phase scheduled for launch by the end of 2024. The company is also planning to expand its services into new markets, specifically targeting regions in North America and Europe by mid-2025.


The recent funding of USD 1 mn from Fanisi Capital will be utilized to support these growth initiatives, enhancing product development and facilitating entry into these new markets.


Current Investors

Fanisi Capital

Primary Industry

Pharmaceuticals

Sub Industries

Pharmaceuticals

Website

www.sopharltd.com

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.